World Orphan Drug Congress USA

With our experience across the product lifecycle in rare disease, UBC looks forward to joining other industry leaders focused on helping rare disease patients at this event.

Across evidence development, safety & risk management, and patient access, our experts bring ample first-hand knowledge to orphan drugs and rare disease. Over 70% of our projects are focused on specialty products or rare diseases and this unique depth of experience enables us to tailor each program to your product and patient requirements.

We are experts at unifying evidence and access, offering flexible solutions for your rare disease programs that generate the relevant real-world data necessary to make informed decisions earlier, meet stakeholder requirements, and drive better patient outcomes.

Connect with our attending team members by completing the form at the right to learn more about our approach and successes in all areas for rare disease and orphan drugs.